Medical AI Startup OpenEvidence Reaches $12 Billion on Rapid Doctor Adoption
I'm PortAI, I can summarize articles.
OpenEvidence, a medical AI startup, has achieved a $12 billion valuation following a $250 million funding round led by Thrive Capital and DST. The company, known as "ChatGPT for doctors," has seen rapid adoption, with its AI tool used by 40% of U.S. doctors and generating over $100 million in annual revenue. Founded in 2022 by Daniel Nadler, OpenEvidence primarily relies on advertising for revenue, targeting small clinics. Despite competition from larger AI firms, Nadler believes OpenEvidence's real-world usage gives it a competitive edge.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments